
PRAX
Praxis Precision Medicines Inc.
$49.20
+$0.87(+1.79%)
90
Overall
--
Value
90
Tech
--
Quality
Market Cap
$888.55M
Volume
631.74K
52W Range
$26.70 - $91.83
Target Price
$100.00
Order:
Income Statement
Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
REVENUE | |||||||
Total Revenue | -- | -- | -- | $2.4M | $8.6M | ||
Total Revenue | -- | -- | -- | $2.4M | $8.6M | ||
GROSS PROFIT | |||||||
Gross Profit | -- | -- | -- | $2.4M | $8.6M | ||
OPERATING EXPENSES | |||||||
Operating Expenses | $62.0M | $167.3M | $215.0M | $128.8M | $208.7M | ||
Research & Development | $45.0M | $120.3M | $155.0M | $86.8M | $152.4M | ||
Research Expense | $45.0M | $120.3M | $155.0M | $86.8M | $152.4M | ||
Selling, General & Administrative | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
General & Administrative Expenses | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
Salaries & Wages | -- | -- | -- | $24.9M | $41.4M | ||
Depreciation & Amortization | $50.0K | $182.0K | $419.0K | $432.0K | $358.0K | ||
Depreciation & Amortization | $50.0K | $182.0K | $419.0K | $432.0K | $358.0K | ||
Other Operating Expenses | $796.0K | $1.4M | $1.1M | $1.1M | $1.1M | ||
OPERATING INCOME | |||||||
Operating income | $-62.0M | $-167.3M | $-215.0M | $-126.4M | $-200.2M | ||
EBITDA | $-61.9M | $-167.2M | $-214.6M | $-122.0M | $-181.5M | ||
NON-OPERATING ITEMS | |||||||
Intinc | $140.0K | $271.0K | $957.0K | -- | -- | ||
Net Non-Operating Interest Income/Expense | $140.0K | $271.0K | $957.0K | -- | -- | ||
Other Income/Expense | -- | -- | $957.0K | $-3.1M | $-17.3M | ||
Other Special Charges | -- | -- | $957.0K | $3.1M | $17.3M | ||
SPECIAL ITEMS | |||||||
Restructring And Mn A Income | -- | -- | $1.0M | -- | -- | ||
Special Income Charges | -- | -- | $-1.0M | -- | -- | ||
PRE-TAX INCOME | |||||||
EBIT | $-62.0M | $-167.3M | $-215.0M | $-123.3M | $-182.8M | ||
Pre-Tax Income | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
INCOME TAX | |||||||
Tax Provision | $-8.0K | -- | -- | -- | -- | ||
NET INCOME | |||||||
Net Income | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
Net Income (Continuing Operations) | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
Net Income (Discontinued Operations) | $-61.8M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
Net Income (Common Stockholders) | $-70.3M | $-167.1M | $-214.0M | $-123.3M | $-182.8M | ||
Normalized Income | -- | -- | -- | -- | $-181.0M | ||
TOTALS | |||||||
Total Expenses | $62.0M | $167.3M | $215.0M | $128.8M | $208.7M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $596.7K | $2.8M | $3.1M | $6.6M | $17.9M | ||
Average Shares Outstanding (Diluted) | -- | $2.8M | $3.1M | $6.6M | $17.9M | ||
Shares Outstanding | $2.6M | $3.0M | $3.5M | $13.2M | $20.2M | ||
Basic EPS | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
Basic EPS (Continuing Operations) | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
Diluted EPS | $-117.9 | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
Diluted EPS (Continuing Operations) | -- | $-59.1 | $-69.6 | $-18.69 | $-10.21 | ||
OTHER METRICS | |||||||
Accrued Preferred Stock Dividends | $8.5M | -- | -- | -- | -- | ||
Other Gand A | $17.0M | $47.1M | $59.9M | $42.1M | $56.3M | ||
Otherunder Preferred Stock Dividend | $8.5M | -- | -- | -- | -- | ||
Preferred Stock Dividends | $8.5M | -- | -- | -- | -- | ||
Restruct | -- | -- | $1.0M | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | PRAX | $49.20 | +1.8% | 631.74K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Praxis Precision Medicines Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW